A 70-year-old woman was subjected to DXA measurement 5 years ago. Her spine T score was -2-9 while the hip T score was -2.0. She has been taking weekly alendronate for 5 years and is concerned about drug side effects. She enjoys good health except for mild hypertension which is well controlled on drugs. What advice will you give her

Given the 70-year-old woman’s history of osteoporosis with low bone mineral density (BMD) and her use of alendronate for the past 5 years, it’s important to address her concerns about potential side effects while also considering the benefits of continued treatment.

Get the full solved assignment PDF of MME-106/As-1 of 2024 session now.

Here’s the advice I would give her:

1. **Review of Benefits and Risks**: Explain to the patient that alendronate, a bisphosphonate medication, is commonly prescribed for the treatment of osteoporosis to help prevent fractures by increasing bone density and reducing bone turnover. Emphasize that the benefits of alendronate in reducing fracture risk have been well established, especially in individuals with low BMD and a history of fractures.

• **Side Effect Profile**: Discuss the potential side effects of alendronate, which may include gastrointestinal symptoms such as heartburn, nausea, and abdominal pain, as well as rare but serious adverse effects such as osteonecrosis of the jaw and atypical femur fractures. Assure the patient that while these side effects can occur, they are relatively uncommon, especially with short-term use.

• **Monitoring and Follow-Up**: Recommend regular monitoring and follow-up with her healthcare provider to assess her response to treatment, evaluate any side effects, and adjust the treatment plan as needed. Routine bone density testing may be recommended periodically to assess the effectiveness of alendronate therapy in maintaining or improving bone density.

• **Lifestyle Modifications**: Encourage the patient to adopt lifestyle modifications that can help improve bone health and reduce fracture risk, including regular weight-bearing exercise, adequate calcium and vitamin D intake, smoking cessation, and moderation of alcohol consumption.

• **Medication Adherence**: Stress the importance of medication adherence in maximizing the benefits of alendronate therapy. Advise the patient to continue taking her medication as prescribed, even if she is concerned about potential side effects, as discontinuing treatment prematurely can increase the risk of fractures.

• **Individualized Risk-Benefit Assessment**: Consider conducting an individualized risk-benefit assessment with the patient, taking into account her overall health status, fracture risk factors, preferences, and concerns. Discuss alternative treatment options, if appropriate, and involve the patient in shared decision-making regarding her osteoporosis management.

• **Address Hypertension Management**: Ensure that the patient’s hypertension is well controlled with appropriate antihypertensive medications and lifestyle modifications. Uncontrolled hypertension can increase the risk of cardiovascular events, which may be of particular concern in older adults with osteoporosis.

• **Open Communication**: Encourage the patient to communicate openly with her healthcare provider about any concerns or questions she may have regarding her osteoporosis treatment. Provide resources and support to help her make informed decisions about her health and well-being.

By providing comprehensive information about the benefits and risks of alendronate therapy, addressing the patient’s concerns, and involving her in the decision-making process, you can help empower her to make informed choices about her osteoporosis management while ensuring her overall health and well-being are optimized.